Skip to main content

Government-approved testing firm valued at $1.7 billion

Government
James Chapple
16 September 2021

UK government-approved Covid testing provider Prenetics has been valued at the best part of US $2 billion ahead of plans for the firm to debut on the New York-based Nasdaq stock exchange.

(Re)open for business

Prenetics, which provides tests at Heathrow and counts Virgin Atlantic and Carnival Cruise Line among its travel clients, is set to merge with Hong Kong’s Artisan Acquisition Corp, creating combined equity value running to US $1.7 billion.


The deal is due to be completed in Q1 2022.


Together, Prenetics and Artisan say they hope "disrupt and decentralise" the global healthcare industry, valuing the opportunity at in excess of US $1.3 billion.


It is the latest indication of the huge value inherent in the global Covid testing market, with most travellers now obliged to take multiple tests to travel.